Role of PPARγ and EGFR signalling in the urothelial terminal differentiation programme

Journal of Cell Science

Volumn 117, Issue 10, 2004, Pages 2029-2036

  Varley, Claire L ^a   Stahlschmidt, Jens ^b   Lee, Wen Chun ^a   Holder, Julie ^c   Diggle, Christine ^a,b   Selby, Peter J ^b   Trejdosiewicz, Ludwik K ^b   Southgate, Jennifer ^a  

^a UNIVERSITY OF YORK   (United Kingdom)

^b ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

^c GLAXOSMITHKLINE   (United Kingdom)

Author keywords

Bladder; Differentiation; Epidermal growth factor; Kinase; Peroxisome proliferator activated receptor; Uroplakin; Urothelium

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 CHLORO 5 NITROBENZANILIDE; 2 MORPHOLINO 8 PHENYLCHROMONE; 4 (3 BROMOANILINO) 6,7 DIMETHOXYQUINAZOLINE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; EPIDERMAL GROWTH FACTOR RECEPTOR; HORMONE RECEPTOR BLOCKING AGENT; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN TYROSINE KINASE INHIBITOR; ROSIGLITAZONE; TROGLITAZONE; UNCLASSIFIED DRUG; UROPLAKIN; 2,4 THIAZOLIDINEDIONE DERIVATIVE; 2-CHLORO-5-NITROBENZANILIDE; 4 ((3 BROMOPHENYL)AMINO) 6,7 DIMETHOXYQUINAZOLINE; 4-((3-BROMOPHENYL)AMINO)-6,7-DIMETHOXYQUINAZOLINE; ANILIDE; CHROMAN DERIVATIVE; ENZYME INHIBITOR; EPIDERMAL GROWTH FACTOR; LIGAND; MEMBRANE PROTEIN; QUINAZOLINE DERIVATIVE; RIBONUCLEASE; UPK1A PROTEIN, HUMAN; UPK1B PROTEIN, HUMAN; UROPLAKIN II; UROPLAKIN III;

ARTICLE; ATTENUATION; AUTOCRINE EFFECT; CELL DIFFERENTIATION; CELL GROWTH; CELL LINE; CELL NUCLEUS; CELL PROLIFERATION; CONTROLLED STUDY; CORRELATION FUNCTION; DOSE RESPONSE; DRUG MECHANISM; DRUG SPECIFICITY; EPITHELIUM; GENE EXPRESSION; HUMAN; HUMAN CELL; MONOCULTURE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DEPHOSPHORYLATION; PROTEIN FUNCTION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; UROTHELIUM; ACTIVE TRANSPORT; ADIPOCYTE; ANIMAL; CATTLE; CYTOLOGY; FLUORESCENCE MICROSCOPY; GENE EXPRESSION REGULATION; IMMUNOPRECIPITATION; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY; PROMOTER REGION; TIME; WESTERN BLOTTING;

ACTIVE TRANSPORT, CELL NUCLEUS; ADIPOCYTES; ANILIDES; ANIMALS; BLOTTING, WESTERN; CATTLE; CELL DIFFERENTIATION; CELL LINE; CELL PROLIFERATION; CHROMANS; ENZYME INHIBITORS; EPIDERMAL GROWTH FACTOR; EPITHELIUM; GENE EXPRESSION REGULATION; HUMANS; IMMUNOPRECIPITATION; LIGANDS; MEMBRANE GLYCOPROTEINS; MEMBRANE PROTEINS; MICROSCOPY, FLUORESCENCE; PHOSPHORYLATION; PPAR GAMMA; PROMOTER REGIONS (GENETICS); QUINAZOLINES; RECEPTOR, EPIDERMAL GROWTH FACTOR; RIBONUCLEASES; RNA, MESSENGER; SIGNAL TRANSDUCTION; THIAZOLIDINEDIONES; TIME FACTORS; UROTHELIUM;

EID: 2942572944     PISSN: 00219533     EISSN: None     Source Type: Journal    
DOI: 10.1242/jcs.01042     Document Type: Article

References (35)

1. Adams, M., Reginato, M. J., Shao, D., Lazar, M. A. and Chatterjee, V. K. (1997). Transcriptional activation by peroxisome proliferator-activated receptor gamma is inhibited by phosphorylation at a consensus mitogen-activated protein kinase site. J. Biol. Chem. 272, 5128-5132.
2. Blanquart, C., Barbier, O., Fruchart, J. C., Staels, B. and Glineur, C. (2003). Peroxisome proliferator-activated receptors: regulation of transcriptional activities and roles in inflammation. J. Steroid Biochem. Mol. Biol. 85, 267-273.
3. Burgermeister, E., Tencer, L. and Liscovitch, M. (2003). Peroxisome proliferator-activated receptor-gamma upregulates caveolin-1 and caveolin-2 expression in human carcinoma cells. Oncogene 22, 3888-3900.
4. Camp, H. S. and Tafuri, S. R. (1997). Regulation of peroxisome proliferator-activated receptor gamma activity by mitogen-activated protein kinase. J. Biol. Chem. 272, 10811-10816.
5. Camp, H. S., Li, O., Wise, S. C., Hong, Y. H., Frankowski, C. L., Shen, X., Vanbogelen, R. and Leff, T. (2000). Differential activation of peroxisome proliferator-activated receptor-gamma by troglitazone and rosiglitazone. Diabetes 49, 539-547.
6. Chang, T. H. and Szabo, E. (2000). Induction of differentiation and apoptosis by ligands of peroxisome proliferator-activated receptor gamma in non-small cell lung cancer. Cancer Res. 60, 1129-1138.
7. Davies, G. F., McFie, P. J., Khandelwal, R. L. and Roesler, W. J. (2002). Unique ability of troglitazone to up-regulate peroxisome proliferator-activated receptor-gamma expression in hepatocytes. J. Pharmacol. Exp. Ther. 300, 72-77.
8. Elnemr, A., Ohta, T., Iwata, K., Ninomia, I., Fushida, S., Nishimura, G., Kitagawa, H., Kayahara, M., Yamamoto, M., Terada, T. et al. (2000). PPARgamma ligand (thiazolidinedione) induces growth arrest and differentiation markers of human pancreatic cancer cells. Int. J. Oncol. 17, 1157-1164.
9. Freeman, M. R., Yoo, J. J., Raab, G., Soker, S., Adam, R. M., Schneck, F. X., Renshaw, A. A., Klagsbrun, M. and Atala, A. (1997). Heparin-binding EGF-like growth factor is an autocrine growth factor for human urothelial cells and is synthesized by epithelial and smooth muscle cells in the human bladder. J. Clin. Invest. 99, 1028-1036.
10. Guan, Y., Zhang, Y., Davis, L. and Breyer, M. D. (1997). Expression of peroxisome proliferator-activated receptors in urinary tract of rabbits and humans. Am. J. Physiol. 273, F1013-F1022.
11. Hicks, R. M. (1975). The mammalian urinary bladder: an accommodating organ. Biol. Rev. Camb. Philos. Soc. 50, 215-246.
12. Jain, S., Pulikuri, S., Zhu, Y., Qi, C., Kanwar, Y. S., Yeldandi, A. V., Rao, M. S. and Reddy, J. K. (1998). Differential expression of the peroxisome proliferator-activated receptor gamma (PPARgamma) and its coactivators steroid receptor coactivator-1 and PPAR-binding protein PBP in the brown fat, urinary bladder, colon, and breast of the mouse. Am. J. Pathol. 153, 349-354.
13. Juge-Aubry, C., Pernin, A., Favez, T., Burger, A. G., Wahli, W., Meier, C. A. and Desvergne, B. (1997). DNA binding properties of peroxisome proliferator-activated receptor subtypes on various natural peroxisome proliferator response elements. Importance of the 5¢-flanking region. J. Biol. Chem. 272, 25252-25259.
14. Kawa, S., Nikaido, T., Unno, H., Usuda, N., Nakayama, K. and Kiyosawa, K. (2002). Growth inhibition and differentiation of pancreatic cancer cell lines by PPAR gamma ligand troglitazone. Pancreas 24, 1-7.
15. Kawakami, S., Arai, G., Hayashi, T., Fujii, Y., Xia, G., Kageyama, Y. and Kihara, K. (2002). PPARgamma ligands suppress proliferation of human urothelial basal cells in vitro. J. Cell Physiol. 191, 310-319.
16. Knock, G. A., Mishra, S. K. and Aaronson, P. I. (1999). Differential effects of insulin-sensitizers troglitazone and rosiglitazone on ion currents in rat vascular myocytes. Eur. J. Pharmacol. 368, 103-109.
17. Lefebvre, M., Paulweber, B., Fajas, L., Woods, J., McCrary, C., Colombel, J. F., Najib, J., Fruchart, J. C., Datz, C., Vidal, H. et al. (1999). Peroxisome proliferator-activated receptor gamma is induced during differentiation of colon epithelium cells. J. Endocrinol. 162, 331-340.
18. Lobban, E. D., Smith, B. A., Hall, G. D., Harnden, P., Roberts, P., Selby, P. J., Trejdosiewicz, L. K. and Southgate, J. (1998). Uroplakin gene expression by normal and neoplastic human urothelium. Am. J. Pathol. 153, 1957-1967.
19. Lowell, B. B. (1999). PPARgamma: an essential regulator of adipogenesis and modulator of fat cell function. Cell 99, 239-242.
20. Mueller, E., Sarraf, P., Tontonoz, P., Evans, R. M., Martin, K. J., Zhang, M., Fletcher, C., Singer, S. and Spiegelman, B. M. (1998). Terminal differentiation of human breast cancer through PPAR gamma. Mol. Cell 1, 465-470.
21. Nakashiro, K. I., Hayashi, Y., Kita, A., Tamatani, T., Chlenski, A., Usuda, N., Hattori, K., Reddy, J. K. and Oyasu, R. (2001). Role of peroxisome proliferator-activated receptor gamma and its ligands in non-neoplastic and neoplastic human urothelial cells. Am. J. Pathol. 159, 591-597.
22. Olsburgh, J., Harnden, P., Weeks, R., Smith, B., Joyce, A., Hall, G., Poulsom, R., Selby, P. and Southgate, J. (2003). Uroplakin gene expression in normal human tissues and locally advanced bladder cancer. J. Pathol. 199, 41-49.
23. Quandt, K., Frech, K., Karas, H., Wingender, E. and Werner, T. (1995). MatInd and MatInspector: new fast and versatile tools for detection of consensus matches in nucleotide sequence data. Nucleic Acids Res. 23, 4878-4884.
24. Sarraf, P., Mueller, E., Jones, D., King, F. J., DeAngelo, D. J., Partridge, J. B., Holden, S. A., Chen, L. B., Singer, S., Fletcher, C. et al. (1998). Differentiation and reversal of malignant changes in colon cancer through PPARgamma. Nat. Med. 4, 1046-1052.
25. Shao, D. and Lazar, M. A. (1997). Peroxisome proliferator activated receptor gamma, CCAAT/enhancer-binding protein alpha, and cell cycle status regulate the commitment to adipocyte differentiation. J. Biol. Chem. 272, 21473-21478.
26. Southgate, J., Hutton, K. A., Thomas, D. F. and Trejdosiewicz, L. K. (1994). Normal human urothelial cells in vitro: proliferation and induction of stratification. Lab. Invest. 71, 583-594.
27. Southgate, J., Masters, J. R. and Trejdosiewicz, L. K. (2002). Culture of human urothelium. In Culture of Epithelial Cells (ed. M. G. Freshney), pp. 381-400. New York: J. Wiley & Sons.
28. Stephens, J. M., Morrison, R. F., Wu, Z. and Farmer, S. R. (1999). PPARgamma ligand-dependent induction of STAT1, STAT5A, and STAT5B during adipogenesis. Biochem. Biophys. Res. Commun. 262, 216-222.
29. Subbaramaiah, K., Lin, D. T., Hart, J. C. and Dannenberg, A. J. (2001). Peroxisome proliferator-activated receptor gamma ligands suppress the transcriptional activation of cyclooxygenase-2. Evidence for involvement of activator protein-1 and CREB-binding protein/p300. J. Biol. Chem. 276, 12440-12448.
30. Thevenon, C., Guichardant, M. and Lagarde, M. (2001). Gas chromatographic-mass spectrometric measurement of 15-deoxy-delta(12,14)-prostaglandin J(2), the peroxisome proliferator-activated receptor gamma ligand, in urine. Clin. Chem. 47, 768-770.
31. Walker, A. B., Naderali, E. K., Chattington, P. D., Buckingham, R. E. and Williams, G. (1998). Differential vasoactive effects of the insulin sensitizers rosiglitazone (BRL 49653) and troglitazone on human small arteries in vitro. Diabetes 47, 810-814.
32. Willson, T. M., Brown, P. J., Sternbach, D. D. and Henke, B. R. (2000). The PPARs: from orphan receptors to drug discovery. J. Med. Chem. 43, 527-550.
33. Wolfertstetter, F., Frech, K., Herrmann, G. and Werner, T. (1996). Identification of functional elements in unaligned nucleic acid sequences by a novel tuple search algorithm. Comput. Appl. Biosci. 12, 71-80.
34. Wu, X. R., Medina, J. J. and Sun, T. T. (1995). Selective interactions of UPIa and UPIb, two members of the transmembrane 4 superfamily, with distinct single transmembrane-domained proteins in differentiated urothelial cells. J. Biol. Chem. 270, 29752-29759.
35. Xu, Y., Iyengar, S., Roberts, R. L., Shappell, S. B. and Peehl, D. M. (2003). Primary culture model of peroxisome proliferator-activated receptor gamma activity in prostate cancer cells. J. Cell Physiol. 196, 131-143.